ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Condition : By Disease Heading : Rare Diseases : Multiple Sclerosis, Relapsing-Remitting

Include trials that are no longer recruiting patients.

4 studies were found.
1.RecruitingTreatment of Multiple Sclerosis using Over the Counter Inosine
Condition: Multiple Sclerosis, Relapsing-Remitting
2.RecruitingZenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
3.RecruitingSafety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects with Multiple Sclerosis (MS)
Conditions: Multiple Sclerosis; Multiple Sclerosis, Relapsing Remitting; Multiple Sclerosis, Secondary Progressive
4.RecruitingRebif® versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act